Search
01/09/2022
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
Melé-Ninot G, Serra-Baldrich E, Spertino J, Guilarte M, Ribó González P, Lleonart-Bellfill R, Figueras-Nart I, Bonfill-Ortí M, Depreux N, Sala-Cunill A, Bielsa-Marsol I, Baliu-Piqué C, Sanmartín-Novell V, Garcia-Navarro X, Expósito-Serrano V, Garnica-Velandia D, Diaz-Sarrió MC, Gómez-Armayones S, Gich Saladich I, Giménez-Arnau A. Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?. EUROPEAN JOURNAL OF DERMATOLOGY. 2022; 32(5)DOI:10.1684/ejd.2022.4334. PMID:36468733. IF:2.500(Q2/5D).
01/09/2022
Hypercapnia and extracorporeal carbon dioxide removal (ECCO2R) in the acute respiratory distress syndrome
Morales-Quinteros, L, Mancebo, J, Del Sorbo, L. Hypercapnia and extracorporeal carbon dioxide removal (ECCO2R) in the acute respiratory distress syndrome. Signa Vitae. 2022; 18(5)DOI:10.22514/sv.2022.046. PMID:. IF:1.100(Q4/9D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 1: Importance of neurofilaments in the management of neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1757. PMID:36453742. IF:0.500(Q4/10D).
01/09/2022
Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases
Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments: a key new biomarker for clinicians Part 2: Neurofilaments, an asset beyond neurodegenerative diseases. ANNALES DE BIOLOGIE CLINIQUE. 2022; 80(5)DOI:10.1684/abc.2022.1758. PMID:36453743. IF:0.500(Q4/10D).
31/08/2022
Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery
Merchan-Galvis, A, Posso, M, Canovas, E, Jordan, M, Aguilera, X, Martinez-Zapata, MJ. Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery. BMC MUSCULOSKELETAL DISORDERS. 2022; 23(1)DOI:10.1186/s12891-022-05775-y. PMID:36045358. IF:2.300(Q2/5D).
31/08/2022
On the necessity of recognizing so-called Core professional groups within the genetic healthcare in Europe (vol 34, pg 81, 2022)
Paneque, M, Juhe, CS, Melegh, B, Carreira, I, Moog, U, Liehr, T. On the necessity of recognizing so-called Core professional groups within the genetic healthcare in Europe (vol 34, pg 81, 2022). Medizinische Genetik. 2022; 34(2)DOI:10.1515/medgen-2022-2122. PMID:. IF:1.100(Q4/10D).